BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1255766)

  • 21. Calmodulin, activated cyclic nucleotide phosphodiesterase, microtubules, and vinca alkaloids.
    Watanabe K; West WL
    Fed Proc; 1982 May; 41(7):2292-9. PubMed ID: 6122611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benomyl and colchicine synergistically inhibit cell proliferation and mitosis: evidence of distinct binding sites for these agents in tubulin.
    Clément MJ; Rathinasamy K; Adjadj E; Toma F; Curmi PA; Panda D
    Biochemistry; 2008 Dec; 47(49):13016-25. PubMed ID: 19049291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cilia regeneration by antineoplastic agents.
    Banerjee S; Margulis L
    Cancer Chemother Rep; 1971 Dec; 55(5):531-7. PubMed ID: 5003619
    [No Abstract]   [Full Text] [Related]  

  • 24. Shape changes and chemokinesis of Walker 256 carcinosarcoma cells in response to colchicine, vinblastine, nocodazole and taxol.
    Keller HU; Zimmermann A
    Invasion Metastasis; 1986; 6(1):33-43. PubMed ID: 2867063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrotubular drugs binding to vinca domain of tubulin.
    Gupta S; Bhattacharyya B
    Mol Cell Biochem; 2003 Nov; 253(1-2):41-7. PubMed ID: 14619954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UA62784 Is a cytotoxic inhibitor of microtubules, not CENP-E.
    Tcherniuk S; Deshayes S; Sarli V; Divita G; Abrieu A
    Chem Biol; 2011 May; 18(5):631-41. PubMed ID: 21609844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural immunocytochemical distribution of tubulin in cultured cells treated with microtubule inhibitors.
    De Brabander M; De May J; Joniau M; Geuens G
    Cell Biol Int Rep; 1977 Mar; 1(2):177-83. PubMed ID: 343926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of antitubulins on spontaneous and chemotactic migration of neutrophils under agarose.
    Dziezanowski MA; DeStefano MJ; Rabinovitch M
    J Cell Sci; 1980 Apr; 42():379-88. PubMed ID: 7400242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
    Jordan MA; Horwitz SB; Lobert S; Correia JJ
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ response to vinka alkaloids by microtubules in cultured post-implanted mouse embryos.
    Meininger V; Binet S; Chaineau E; Fellous A
    Biol Cell; 1990; 68(1):21-9. PubMed ID: 2180513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
    Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
    Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The formation of annulated lamellae induced by the disintegration of microtubules.
    De Brabander M; Borgers M
    J Cell Sci; 1975 Nov; 19(2):331-40. PubMed ID: 1104645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced expression of Epstein-Barr virus early antigens by antitubulin agents in a latently infected human lymphoblastoid cell line.
    Fujita J; Yoshida O; Tokuda H; Sugawara K; Ito Y
    Experientia; 1985 Mar; 41(3):372-3. PubMed ID: 2982647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microtubule-binding natural products for cancer therapy.
    Yue QX; Liu X; Guo DA
    Planta Med; 2010 Aug; 76(11):1037-43. PubMed ID: 20577942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.
    Himes RH; Kersey RN; Heller-Bettinger I; Samson FE
    Cancer Res; 1976 Oct; 36(10):3798-802. PubMed ID: 954003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine.
    Sertel S; Fu Y; Zu Y; Rebacz B; Konkimalla B; Plinkert PK; Krämer A; Gertsch J; Efferth T
    Biochem Pharmacol; 2011 Mar; 81(6):723-35. PubMed ID: 21219884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Microtubule Drugs.
    Florian S; Mitchison TJ
    Methods Mol Biol; 2016; 1413():403-21. PubMed ID: 27193863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of drugs affecting microtubular assembly on microtubules, phospholipid synthesis and physiological indices (signalling, growth, motility and phagocytosis) in Tetrahymena pyriformis.
    Kovács P; Csaba G
    Cell Biochem Funct; 2006; 24(5):419-29. PubMed ID: 15912561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibitors of microtubule polymerization- new natural compounds as potential anti-cancer drugs].
    Rogalska A; Miśkiewicz K; Marczak A
    Postepy Hig Med Dosw (Online); 2015 May; 69():571-85. PubMed ID: 25983296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microtubules as drug receptors: pharmacological properties of microtubule protein.
    Wilson L
    Ann N Y Acad Sci; 1975 Jun; 253():213-31. PubMed ID: 1096718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.